SOD1 and amyotrophic lateral sclerosis: Multiple compounds with reported effects on SOD1 function and deposition are currently underway in clinical trials for SOD1‐linked familial ALS and sporadic ALS (Table 3), following improvements in survival and motor function in mutant SOD1 murine models of ALS.